- Report
- June 2024
- 140 Pages
Europe
From €3433EUR$3,869USD£2,996GBP
- Report
- April 2023
- 147 Pages
Global
From €4391EUR$4,949USD£3,833GBP
- Report
- December 2023
- 231 Pages
Global
€4431EUR$4,995USD£3,868GBP
- Report
- July 2024
- 153 Pages
Global
From €3205EUR$3,613USD£2,798GBP
€3771EUR$4,250USD£3,291GBP
- Report
- October 2023
- 146 Pages
Global
From €3130EUR$3,528USD£2,732GBP
€3682EUR$4,150USD£3,214GBP
- Report
- September 2024
- 150 Pages
Global
From €3416EUR$3,850USD£2,981GBP
€4303EUR$4,850USD£3,756GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4347EUR$4,900USD£3,795GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4347EUR$4,900USD£3,795GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4347EUR$4,900USD£3,795GBP
- Report
- August 2023
- 300 Pages
Europe
From €4347EUR$4,900USD£3,795GBP
- Report
- August 2023
- 1300 Pages
Global
From €7896EUR$8,900USD£6,892GBP
- Report
- August 2023
- 51 Pages
South Korea
From €532EUR$600USD£465GBP
- Report
- August 2023
- 51 Pages
Mexico
From €532EUR$600USD£465GBP
- Report
- August 2023
- 51 Pages
Canada
From €532EUR$600USD£465GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €532EUR$600USD£465GBP
From €532EUR$600USD£465GBP
- Report
- August 2023
- 51 Pages
Germany
From €532EUR$600USD£465GBP
- Report
- August 2023
- 51 Pages
France
From €532EUR$600USD£465GBP
- Report
- August 2023
- 51 Pages
United States
From €532EUR$600USD£465GBP
- Report
- August 2023
- 51 Pages
Australia
From €532EUR$600USD£465GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more